Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Acute Uncomplicated Influenza
NCT02612922Phase 3Completed
- Sponsor
- Romark Laboratories
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of nitazoxanide in influenza, sponsored by Romark Laboratories. Started Dec 2015; status: completed.
02
Drugs
nitazoxanide
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02612922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612922.